Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Healthcare Realty Trust | HR | Nov 1, 2024 | 16.92 | -1.51 |
Healthcare Select Sector SPDR | XLV | Nov 1, 2024 | 147.74 | +0.59 |
Healthcare Services Group | HCSG | Nov 1, 2024 | 11.15 | +1.64 |
Healthcare Triangle | HCTI | Nov 1, 2024 | 1.29 | -5.15 |
HealthEquity | HQY | Nov 1, 2024 | 86.33 | +1.27 |
Healthpeak Properties | DOC | Nov 1, 2024 | 21.98 | -2.09 |
HealthStream | HSTM | Nov 1, 2024 | 29.33 | +0.33 |
Healthy Choice Wellness | HCWC | Nov 1, 2024 | 1.65 | 0.00 |
Heartbeam | BEAT | Nov 1, 2024 | 2.49 | +2.89 |
Heartcore Enterprises | HTCR | Nov 1, 2024 | 1.15 | +11.65 |
Heartland Express | HTLD | Nov 1, 2024 | 10.91 | +0.97 |
Heartland Financial E Pref | HTLFP | Nov 1, 2024 | 25.06 | +0.32 |
Heartland Financial USA | HTLF | Nov 1, 2024 | 58.67 | -1.40 |
HeartSciences | HSCS | Nov 1, 2024 | 2.90 | -1.36 |
Hecla Mining | HL | Nov 1, 2024 | 6.40 | -1.39 |
Hecla Mining B Pref | HL-B | Nov 1, 2024 | 54.00 | 0.00 |
Hedge Replication ETF Proshares | HDG | Nov 1, 2024 | 49.72 | +0.38 |
Heico | HEI | Nov 1, 2024 | 245.86 | +0.37 |
Heico A | HEI-A | Nov 1, 2024 | 192.25 | +0.13 |
Heidrick & Struggles International | HSII | Nov 1, 2024 | 39.28 | +0.56 |
Helen of Troy | HELE | Nov 1, 2024 | 64.78 | +1.78 |
Helios Technologies | HLIO | Nov 1, 2024 | 47.95 | +3.95 |
Helius Medical Technologies A | HSDT | Nov 1, 2024 | 0.51 | -0.20 |
Helix Acquisition II | HLXB | Nov 1, 2024 | 10.59 | +1.63 |
Helix Energy Solutions Group | HLX | Nov 1, 2024 | 9.18 | -0.76 |
Hello ADR | MOMO | Nov 1, 2024 | 7.10 | +0.42 |
Helmerich & Payne | HP | Nov 1, 2024 | 32.93 | -1.99 |
Helport AI Limited - Ordinary Shares | HPAI | Nov 1, 2024 | 6.49 | 0.00 |
Hennessy Advisors | HNNA | Nov 1, 2024 | 10.10 | -0.78 |
Hennessy Capital Investment VI SPAC A | HCVI | Nov 1, 2024 | 10.52 | +0.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.